Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 765 shares at $7.70 ($6K) on 2024-03-27, disclosed to the SEC on 2024-03-29.
Seasonal sale ($6k) by President, R&D — this insider has traded RLAY in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-07-08 | $162K | — | Filing → |
| RLAY | SELL | 2026-06-24 | $1.6M | — | Filing → |
| RLAY | SELL | 2026-04-30 | $22K | — | Filing → |